Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

The treatment helped reduce symptoms and stabilize the hairline in most patients with Frontal Fibrosing Alopecia, but hair regrowth was limited.

There are many treatments for permanent hair loss disorders, but their effectiveness varies and there's no clear best option.

To diagnose hair loss, use a systematic approach including history, exams, and tests.

Changes to the Foxp3 protein affect how well regulatory T cells can control the immune system, which could help treat immune diseases and cancer.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

Advanced human skin models improve drug development and could replace animal testing.

FFA's causes may include environmental triggers and genetic factors.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

Exosomes can improve skin health and offer new treatments for skin repair and rejuvenation.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

Plasmacytoid dendritic cells are a key factor in causing hair loss in alopecia areata and could help differentiate it from other hair loss conditions.

The book is recommended for its new scientific information and balanced treatment options for hair loss in domestic animals.

Special immune cells called Regulatory T cells help control skin inflammation and repair in various skin diseases.

Minoxidil 2% effectively treats female hair loss, promoting growth and density.

CRAC channels are crucial for the development and function of specialized immune cells, preventing severe inflammation and autoimmune diseases.

Early and personalized treatment for hair loss in young people is crucial to prevent permanent damage and should include psychological support.

Rituximab leads to longer remission and fewer side effects than cyclophosphamide.

Early detection and stopping the drug are key to managing DRESS, and careful monitoring is important due to possible severe reactions.

People with pemphigus are more likely to have conditions like hypothyroidism, inflammatory bowel disease, and diabetes.

Pregnancy can change skin disease severity, with some conditions improving and others worsening, and treatment should balance benefits and fetal safety.

Type I interferons play a key role in the development of various skin diseases.

Targeting CD200 could be a new treatment for rheumatoid arthritis.

People with lichen planus are more likely to have dyslipidemia, especially higher triglyceride levels.

People with Lichen Planus, especially with mucosal involvement, are more likely to have Metabolic Syndrome, which increases their risk for heart disease and diabetes.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Finasteride improves hair growth.

Looking at skin can help find and treat serious diseases early.